Tiny study tests diuretics for dialysis patients – terminated early
NCT ID NCT05915286
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested two diuretics (furosemide and chlorthalidone) in people on dialysis who still had some kidney function. The goal was to see if these water pills could help preserve remaining kidney function, increase urine output, and reduce weight gain between dialysis sessions. Only 2 participants were enrolled, and the study was terminated early, so no firm conclusions can be drawn.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Furosemide and chlorthalidone (water pills)
What this could lead to
If it works, this could point toward a way to help dialysis patients keep some kidney function and reduce fluid buildup between treatments.
What could go wrong
This was a very small pilot study (only 2 participants) that was terminated early, so results are not reliable. It is too early to know if diuretics are safe or effective for dialysis patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE ON DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alberta
Edmonton, Alberta, T6G 2B7, Canada